Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney
cancer (advanced renal cell carcinoma), advanced primary liver cancer ...
Sorafenib (Nexavar) side effects, what it's used for, how it's given, how it works,
drug type, precautions and self care tips.
Aug 15, 2016 ... Sorafenib: learn about side effects, dosage, special precautions, and more on
Apr 29, 2015 ... Read about the cancer treatment drug sorafenib, otherwise known as Nexavar,
including what it is, how it works and possible side effects.
Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved
sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...
sorafenib tosylate: Patient Information: The tosylate salt of sorafenib, a synthetic
compound targeting growth signaling and angiogenesis. Sorafenib blocks the ...
Jan 13, 2016 ... Sorafenib (Nexavar®) is an oral multikinase inhibitor used in the treatment of liver
, kidney and thyroid cancers.
Find patient medical information for sorafenib oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Sorafenib (Nexavar) is an orally active multikinase inhibitor that is approved in
the EU for the treatment of hepatocellular carcinoma. Monotherapy with sorafenib
Learn about Nexavar (Sorafenib) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.